Abstract
Introduction: Brachytherapy is a treatment in which sealed radioactive sources are used to deliver high doses of radiation at close distance to the tumor with rapid dose fall-off in the surrounding normal tissue resulting in high therapeutic ratio in oncological disease management. It is effective in palliative treatment for patients with symptoms of hemoptysis and dysnea resulting from endobronchial obstruction.
Conclusion: In spite of the rapid development of external beam radiation therapy brachytherapy continues to remain an important mode of therapy and is often a default treatment when external beam radiation option is limited.
Keywords: Lung cancer, non-small cell, brachytherapy, High Dose Rate (HRD), treatment, tumor.
Current Cancer Therapy Reviews
Title:Lung Cancer Brachytherapy
Volume: 14 Issue: 2
Author(s): Edward Yu*Craig Lewis
Affiliation:
- Department of Oncology, Western University, Ontario, ON N6A-4L6,Canada
Keywords: Lung cancer, non-small cell, brachytherapy, High Dose Rate (HRD), treatment, tumor.
Abstract: Introduction: Brachytherapy is a treatment in which sealed radioactive sources are used to deliver high doses of radiation at close distance to the tumor with rapid dose fall-off in the surrounding normal tissue resulting in high therapeutic ratio in oncological disease management. It is effective in palliative treatment for patients with symptoms of hemoptysis and dysnea resulting from endobronchial obstruction.
Conclusion: In spite of the rapid development of external beam radiation therapy brachytherapy continues to remain an important mode of therapy and is often a default treatment when external beam radiation option is limited.
Export Options
About this article
Cite this article as:
Yu Edward *, Lewis Craig , Lung Cancer Brachytherapy, Current Cancer Therapy Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/1573394714666180208145420
DOI https://dx.doi.org/10.2174/1573394714666180208145420 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Platelet-Rich and Platelet-Poor Plasma Might Play Supportive Roles in Cancer Cell Culture: A Replacement for Fetal Bovine Serum?
Anti-Cancer Agents in Medicinal Chemistry Mutagenesis by Environmental Pollutants and Bio-Monitoring of Environmental Mutagens
Current Drug Metabolism Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry Subcellular Trafficking in Rhabdovirus Infection and Immune Evasion: A Novel Target for Therapeutics
Infectious Disorders - Drug Targets Modulation of MicroRNAs by <i>Euphorbia Microsciadia</i> Boiss in MDA-MB-231 Cell Line: New Possibilities in Breast Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Applications and Toxicity of Silver Nanoparticles: A Recent Review
Current Topics in Medicinal Chemistry Potassium Channels are a New Target Field in Anticancer Drug Design
Recent Patents on Anti-Cancer Drug Discovery RNA Interference in Cancer: Targeting the Anti-Apoptotic Protein c-FLIP for Drug Discovery
Mini-Reviews in Medicinal Chemistry Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design HGF-Antagonists: Structure, Activities, and Anti-cancer Approach
Current Signal Transduction Therapy Synthesis, Molecular Docking, in vitro Antiproliferative and Antioxidant Activity of Novel Pyrrolidinyl-Carbazole Derivatives
Current Organic Synthesis Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology Carbon Nanotubes – Curse or Blessing
Current Medicinal Chemistry Roles of Nicotinic Acetylcholine Receptors in Stem Cell Survival/Apoptosis, Proliferation and Differentiation
Current Molecular Medicine Small Molecules for Immunomodulation in Cancer: A Review
Anti-Cancer Agents in Medicinal Chemistry Clioquinol – A Novel Copper-Dependent and Independent Proteasome Inhibitor
Current Cancer Drug Targets Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy
Current Drug Targets Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors
Current Drug Targets Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
Anti-Cancer Agents in Medicinal Chemistry